Search

everythinglearnresearchcommunity

for

Search:↓

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Targeted cancer therapies often cause serious skin problems that need careful management.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

The FDA approved a new Pfizer drug for hair loss in teens.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Erlotinib can cause hair loss and texture changes.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib effectively treats Alopecia Areata.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Specific mutations in a receptor cause facial abnormalities and hair loss.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.